Sort
50,496 grants matching “lung cancer”
Impact of Cryptococcus Titan Cells on Pathogenesis.
$502,026Kirsten Nielsen · University Of Minnesota · R01 · FY2021 · AI
Impact of Cryptococcus Titan Cells on Pathogenesis.
$502,026Kirsten Nielsen · University Of Minnesota · R01 · FY2022 · AI
Impact of Cryptococcus Titan Cells on Pathogenesis.
$502,026Kirsten Nielsen · University Of Minnesota · R01 · FY2019 · AI
Impact of Cryptococcus Titan Cells on Pathogenesis.
$502,026Kirsten Nielsen · University Of Minnesota · R01 · FY2020 · AI
Training in Molecular & Genetic Epidemiology of Cancer
$502,022John S Witte · University Of California, San Francisco · R25 · FY2007 · CA
Optimizing Personalized Screening and Diagnostic Decisions for Lung Cancer Based on Dynamic Risk Assessment and Life Expectancy
$502,013Iakovos Toumazis · University Of Tx Md Anderson Can Ctr · R37 · FY2024 · CA
IND-Enabling Toxicology for a Novel Ca2+ Channel Therapeutic to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy
$502,010Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2024 · CA
miR-155 targeted therapeutics for precision medicine in lung cancer
$501,986George A. Calin · University Of Tx Md Anderson Can Ctr · R01 · FY2022 · CA
Computational Tools for Next Generation Volumetric Cone Beam Computed Tomography
$501,863Lei Xing · Stanford University · R01 · FY2014 · EB
Metabolism of Carcinogenic Tobacco-Specific Nitrosamines
$501,839Stephen S Hecht · University Of Minnesota · R37 · FY2011 · CA
Interpretable graphical models for large multi-modal COPD data (R01HL159805)
$501,802Panagiotis V Benos · University Of Florida · R01 · FY2022 · HL
Nanoparticles-mediated combination therapy for breast cancer
$501,746Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Systematic Error and Confounding: Meta-Analyses of Alcohol and Disease
$501,598Kaye M Fillmore · Scientific Analysis Corporation · R01 · FY2012 · AA
Quantitative Imaging to Assess Response in Cancer Therapy Trials
$501,587John M Buatti · University Of Iowa · U01 · FY2014 · CA
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.
$501,565Leah J Siskind · University Of Louisville · R01 · FY2020 · DK
The role of neutral ceramidase in acute kidney injury and its progression to chronic kidney disease.
$501,565Leah J Siskind · University Of Louisville · R01 · FY2021 · DK
Contribution of development and age to breast cancer etiology
$501,556Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2017 · CA
Roles of p63 in regulation of miRNA and LincRNA targets in metastatic cancer
$501,539Elsa R Flores · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
NAPTA: Optimizing clinical trial design & delivery of particle therapy for cancer
$501,487Mack Roach · University Of California, San Francisco · P20 · FY2015 · CA
Project 2: Functional Genetic Networks for Systems-Guided Precision Medicine
$501,398Stephanie Irene Fraley · University Of California, San Francisco · U54 · FY2023 · CA
Risk Factors for Sepsis in the Community
$501,341Henry E Wang · University Of Alabama At Birmingham · R01 · FY2014 · NR
Outcomes of Triaged Family Care in Advanced Cancer
$501,336Laurel L. Northouse · University Of Michigan At Ann Arbor · R01 · FY2006 · CA
Tumor cell metabolism in action
$501,299Eileen White · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
Leadership, Planning, and Evaluation
$501,296Kelvin P Lee · Indiana University Indianapolis · P30 · FY2020 · CA
Leadership, Planning, and Evaluation
$501,296Patrick J Loehrer · Indiana University Indianapolis · P30 · FY2022 · CA